Clinical trial
Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy…
NCT00368238 · Yale University, Other · Completed
Key facts
| NCT number | NCT00368238 |
|---|---|
| Title | Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects |
| Official title | Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects |
| Lead sponsor | Yale University, Other |
| Collaborators | American Heart Association |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | Recombinant human erythropoietin alfa (drug), Aspirin (drug), Clopidogrel (drug) |
| Enrollment | 96 |
| Start date | Oct 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Aug 24, 2006 |
| Last update posted | Aug 24, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: